SciELO - Scientific Electronic Library Online

 
vol.60 número10Metástasis cutánea solitaria de carcinoma vesical índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Archivos Españoles de Urología (Ed. impresa)

versión impresa ISSN 0004-0614

Resumen

CORTES GONZALEZ, Jeff R.; ORTIZ LARA, Gerardo E.; ARRATIA MAQUEO, Jorge A.  y  GOMEZ GUERRA, Lauro S.. Continuous bladder irrigation with amikacin as adjuvant treatment for emphysematous cystitis. Arch. Esp. Urol. [online]. 2007, vol.60, n.10, pp.1218-1220. ISSN 0004-0614.

Objective: To demonstrate that continuos intravesical irrigation with amikacin is an efective adyuvant treatment in Emphisematous Cistitis therapy. Methods: A 3 way transurethral Foley catheter was placed and a continuous intravesical irrigation was initiated with amikacin 500mg in 1L of normal saline (500 micrograms per ml) within 6 hours 4 times a day and three consecutive days. Results: After 3 days of treatment the patient showed significant clinical response. A new CT scan showed the absence of gas in the bladder wall compared to the previews CT and negative urine culture was obtained. Conclusions: We established that treatment using adjuvant continuous intravesical irrigation with amikacin can reduce hospital stay and accelerate the patient’s healing process, as well as an earlier negativisation of urine cultures. A comparative prospective study is needed to evaluate if in fact this treatment variant produces a real benefit compared to conventional therapy.

Palabras clave : Emphysematous cystitis; Intravesical irrigation; Urinary tract infection; Amikacin.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons